%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D8%B1%D8%A6%D9%88%D9%8A_%D9%8A%D9%88%D8%B2%D9%8A%D9%86%D9%8APneum%C3%B2nia_eosinof%C3%ADlicaEosinophilic_pneumoniaNeumon%C3%ADa_eosinof%C3%ADlicaEosinofilia_pulmonarPolmonite_eosinofila%E5%A5%BD%E9%85%B8%E7%90%83%E6%80%A7%E8%82%BA%E7%82%8EOstre_eozynofilowe_zapalenie_p%C5%82ucPneumonia_eosinof%C3%ADlica%D0%AD%D0%BE%D0%B7%D0%B8%D0%BD%D0%BE%D1%84%D0%B8%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F_%D0%BF%D0%BD%D0%B5%D0%B2%D0%BC%D0%BE%D0%BD%D0%B8%D1%8FNimonia_esinofiliQ32540
about
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaImpact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic AsthmaA Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic AsthmaEfficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaIdentifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe AsthmaEffect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic AsthmaEvaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRIUtilisation of Benralizumab in the Clinical Practise in Severe Eosinophilic Asthma Patients in SwitzerlandIntense Airway Eosinophilia in AsthmaOpen-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaA Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaA Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaUsefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Bacterial PneumoniaPatient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY StudyEfficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlA Phase IIa Study of KHK4563The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic PneumoniaBenralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody TherapiesProof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic AsthmaCessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsA Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma PatientsA Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaStudy to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in SpainMepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in GreeceA Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With BenralizumabEffects of Anti-IL5 Biological Treatments of Blood IgE Levels in Severe Asthmatic PatientsEfficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic AsthmaDexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic AsthmaEuropean Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and BiobankOmalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsEffect of OC000459 on Eosinophilic Airway Inflammation in Severe AsthmaAnti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic AsthmaChange in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life ConditionsEosinophils Endotypes in Chronic Airway Inflammatory DiseasesPatient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium
P1050
Role of oxidants in interstitial lung diseases: pneumoconioses, constrictive bronchiolitis, and chronic tropical pulmonary eosinophiliaTropical pulmonary eosinophilia--a reviewIdiopathic chronic eosinophilic pneumonia.Eosinophilic airway inflammation in COPDTumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the LiteratureSevere eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.Drug-induced eosinophilic pneumonia: A review of 196 case reports.Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin
P921
Q61956496-1426B251-3992-4111-B694-BE893C3306EAQ62025265-D49CBF6D-0942-4965-8B45-11FDD38191E3Q62035162-82A47332-E9FD-4BE4-A9EB-44C0B92213A1Q63338914-9BB03430-29E6-493E-843F-821BE4525556Q63399213-E5ADA515-03A4-4A2D-B9B8-EAF0CB6CC061Q63400648-4778509F-CC3C-48A1-BB5A-ED9F96E03967Q63587745-25CD7909-EB06-4DDB-A2FA-376850CA47F9Q63587768-AED22274-9795-44FF-BF9D-37A40972D2F9Q63598209-8D9C00DB-147D-4746-8BF3-7E026E1AA5D2Q63814133-B441FCF8-EDB3-493C-820C-7A683AC9F93DQ63814430-ECB6A2EB-D324-4E32-A508-C8442A3605A2Q63815968-B8772ED6-CC3C-4236-881B-AE54E9AD6332Q63829244-ED2C7D28-4724-4EAE-98C3-040C35B9FA93Q64172604-806F6D60-78A4-4071-9729-3C93510937A6Q64216854-94307C10-301F-4B83-A3CE-06115DF7247AQ64599971-E4958FA1-8088-41D9-A4E2-6B6B3B1847B3Q64660404-1526BDD5-11F4-4A28-8492-A00CB581A6EAQ64721446-BAC3DD3C-559D-4597-B91A-C9AD9EC8F42FQ64804082-6D830E55-73E8-45DF-9FA5-E20511A2C6E3Q64804159-28A1BB66-456E-4FC4-A3F8-58FAC7C35304Q65330663-4E20ADAD-36A7-4005-8D0C-9F29DE5575D8Q65374405-D11D8BE2-2507-4231-AFAE-595AD93ADBCAQ66066344-BB291262-D93F-4D8C-9F1F-661AF626E349Q66072850-F6AC8810-CEB0-4C96-B3CB-6D9E1D6C67F8Q74277170-4DCE1C9C-8180-498E-AD59-CCA325CF0DDFQ74283904-0978839C-A026-402C-9B8D-CD5FAC3717F7Q76979577-A4D96AD7-69B3-4032-9EDA-4C1A70774A56Q76980886-B3B6B3D6-F7A4-4C32-9787-F56FCFC8C298Q76981982-3F35797E-71CD-41D2-AC1A-4C258568D30BQ76981985-BF9F4328-D372-4431-BC72-17B1D92F5C63Q76982448-F27A983F-040D-4D9E-B14D-2A848BE771B3Q76982589-E1E3D1BC-727D-49A3-836F-949AF4C2725DQ76982670-E822078E-B14A-4BCC-BD7A-BF06D6EFC653Q76982673-A73821F7-C334-4513-806C-8A6A407965BFQ79109991-7D2A7BD9-089E-4D00-BC0A-1B187BA1257CQ79110751-B5D15764-E1EA-4918-A129-963C48353073Q83807634-43A4CD23-8E94-4834-B04F-C8C1509C9AD9
P1050
Q26824848-75A2C6C6-F610-47A8-99EA-E6A835190A64Q27009456-D6B590E5-A536-4873-AD53-C6810E81487BQ34624726-25CA60C2-AAD1-4113-8680-A8FA67254364Q37018920-8EE096AD-E767-494E-848F-6D55BADC9D0CQ37414397-E5581CB0-FD01-49D5-B521-B94EED87E167Q45676532-74A31526-5539-445F-8915-67BD87859EF7Q47647740-0BDE7155-56D5-408B-9595-C9B6A9FD5A8CQ49751199-48194C6C-8A56-4965-AC74-32E6E415F6D3Q96179043-ED342A6C-316C-453B-B189-01BA2D684136
P921
description
Krankheit
@de
disease in which an eosinophil, a type of white blood cell, accumulates in the lung
@en
malattia dell'apparato respiratorio
@it
name
Eosinofilia pulmonar
@gl
Nimonia esinofili
@sw
Ostre eozynofilowe zapalenie płuc
@pl
eosinofil pneumoni
@nn
eosinophilic pneumonia
@en
neumonía eosinofílica
@es
pneumonia eosinofílica
@pt
pneumopathie à éosinophiles
@fr
pneumònia eosinofílica
@ca
polmonite eosinofila
@it
type
label
Eosinofilia pulmonar
@gl
Nimonia esinofili
@sw
Ostre eozynofilowe zapalenie płuc
@pl
eosinofil pneumoni
@nn
eosinophilic pneumonia
@en
neumonía eosinofílica
@es
pneumonia eosinofílica
@pt
pneumopathie à éosinophiles
@fr
pneumònia eosinofílica
@ca
polmonite eosinofila
@it
altLabel
EP
@en
Eosinophilic pneumonia
@ar
PIE症候群
@ja
Pneumonia, eosinophilic
@en
eosinofil lungebetennelse
@nn
eosinofilia pulmonar
@es
eosinofília pulmonar
@ca
neumonía eosinofila
@es
pneumonie éosinophilique
@fr
poumon éosinophile
@fr
prefLabel
Eosinofilia pulmonar
@gl
Nimonia esinofili
@sw
Ostre eozynofilowe zapalenie płuc
@pl
eosinofil pneumoni
@nn
eosinophilic pneumonia
@en
neumonía eosinofílica
@es
pneumonia eosinofílica
@pt
pneumopathie à éosinophiles
@fr
pneumònia eosinofílica
@ca
polmonite eosinofila
@it
P2888
P486
P6366
P646
P1692
P1748
P1995
P2892
P31
P486
P5082
eosinofil_pneumoni
P5270
MONDO:0005749
P604
P6366
2780942278
2908924078
P646
P672
C08.381.750
C15.378.553.231.549.750